Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: opalapril who wrote (8303)	1/15/1999 3:25:00 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

Seems like someone likes XOMA. a one min. graph, "delayed" shows 40,000 shares traded in one min. I know it has been really difficult and in fact unprofitable to stick with XOMA. But the promise has been so attractive and interesting that some of us did for one reason or another. We and XOMA are now approaching a decisive moment. I realize Neuprex has not yet been proven to be effective and that some will say it does not matter if it is. The gonzalea post is important. The delay far from indicating Neuprex is not effective could indicate the contrary. OFF TOPIC: I thought I was taking PCP but you say it's PRD, guess I will have to check my supplier.